2026 Global: Cardiac Catheter Sensor Market -Competitive Review (2032) report
Description
The 2026 Global: Cardiac Catheter Sensor Market -Competitive Review (2031) report features the global market size and projected growth/decline data for the period 2021 through 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for cardiac catheter sensor market by geography and historical trend. The scope of the report extends to sizing of the cardiac catheter sensor market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
Abbott Laboratories, Medtronic plc, Boston Scientific, Johnson & Johnson MedTech (including Biosense Webster), Terumo Corporation, B. Braun Melsungen, Philips (Image-Guided Therapy), Edwards Lifesciences, Cardinal Health/Cordis, and Asahi Intecc are widely recognized as ten major companies active in the cardiac catheter sensor and related catheter/guidewire markets. Abbott is a leader with sensor-enabled diagnostic and electrophysiology catheters such as contact‑force sensing and pulse-field ablation systems that integrate sensing for mapping and lesion assessment, and the company’s broad cardiovascular portfolio and large global footprint reinforce its market position. Medtronic offers an extensive interventional cardiology lineup including sensor-embedded guidewires and mapping/ablation catheters (affording real‑time physiological measurements) and continues to expand with mapping systems and novel energy modalities that pair sensors with therapy delivery. Boston Scientific’s portfolio spans diagnostic and therapeutic catheters with increasing emphasis on sensor integration for imaging, navigation, and ablation workflows, and its electrophysiology and structural-heart offerings strengthen its role in sensor-enabled catheter adoption. Johnson & Johnson MedTech (and subsidiary Biosense Webster) is prominent in electrophysiology mapping and ablation, producing sensorized catheters and mapping platforms used for high‑resolution intracardiac sensing and lesion assessment.
Terumo Corporation and B. Braun are key global catheter and guidewire manufacturers supplying sensor-capable guidewires, access systems, and diagnostic catheters used in cardiac catheterization labs; their broad interventional portfolios and strong regional presences support adoption of sensor-embedded devices in routine practice. Philips, through its Image‑Guided Therapy division, combines advanced imaging, catheter navigation, and sensing technologies to deliver integrated cath‑lab solutions where catheter sensors feed into imaging and workflow systems for procedural guidance. Edwards Lifesciences—while best known for structural heart valves—has moved into sensor-equipped delivery systems and procedural monitoring tools that interface with catheter platforms for transcatheter structural interventions, enhancing safety and intraoperative feedback. Cardinal Health’s Cordis business and Asahi Intecc are influential suppliers of guidewires, diagnostic and interventional catheters, and specialty sensor‑ready guidewires; Cordis’s commercial reach and Asahi’s technical expertise in wire and catheter materials support their roles in enabling sensor integration across catheter types.
Collectively these ten companies cover the spectrum from sensor‑embedded guidewires and contact‑force or pressure‑sensing diagnostic catheters to mapping/ablation systems and integrated cath‑lab platforms; market reports and industry analyses list these firms repeatedly as market leaders or key competitors in cardiac catheter, guidewire, and sensor‑based catheter segments due to their product breadth, regulatory footprints, and R&D pipelines. Their strategic activities include product launches, CE and FDA clearances, acquisitions and partnerships to combine sensing, imaging, and navigation, and continued investment in pulsed‑field, contact‑force, and pressure/flow sensor technologies that aim to streamline procedures and provide real‑time physiological data to clinicians.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for cardiac catheter sensor market by geography and historical trend. The scope of the report extends to sizing of the cardiac catheter sensor market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
Abbott Laboratories, Medtronic plc, Boston Scientific, Johnson & Johnson MedTech (including Biosense Webster), Terumo Corporation, B. Braun Melsungen, Philips (Image-Guided Therapy), Edwards Lifesciences, Cardinal Health/Cordis, and Asahi Intecc are widely recognized as ten major companies active in the cardiac catheter sensor and related catheter/guidewire markets. Abbott is a leader with sensor-enabled diagnostic and electrophysiology catheters such as contact‑force sensing and pulse-field ablation systems that integrate sensing for mapping and lesion assessment, and the company’s broad cardiovascular portfolio and large global footprint reinforce its market position. Medtronic offers an extensive interventional cardiology lineup including sensor-embedded guidewires and mapping/ablation catheters (affording real‑time physiological measurements) and continues to expand with mapping systems and novel energy modalities that pair sensors with therapy delivery. Boston Scientific’s portfolio spans diagnostic and therapeutic catheters with increasing emphasis on sensor integration for imaging, navigation, and ablation workflows, and its electrophysiology and structural-heart offerings strengthen its role in sensor-enabled catheter adoption. Johnson & Johnson MedTech (and subsidiary Biosense Webster) is prominent in electrophysiology mapping and ablation, producing sensorized catheters and mapping platforms used for high‑resolution intracardiac sensing and lesion assessment.
Terumo Corporation and B. Braun are key global catheter and guidewire manufacturers supplying sensor-capable guidewires, access systems, and diagnostic catheters used in cardiac catheterization labs; their broad interventional portfolios and strong regional presences support adoption of sensor-embedded devices in routine practice. Philips, through its Image‑Guided Therapy division, combines advanced imaging, catheter navigation, and sensing technologies to deliver integrated cath‑lab solutions where catheter sensors feed into imaging and workflow systems for procedural guidance. Edwards Lifesciences—while best known for structural heart valves—has moved into sensor-equipped delivery systems and procedural monitoring tools that interface with catheter platforms for transcatheter structural interventions, enhancing safety and intraoperative feedback. Cardinal Health’s Cordis business and Asahi Intecc are influential suppliers of guidewires, diagnostic and interventional catheters, and specialty sensor‑ready guidewires; Cordis’s commercial reach and Asahi’s technical expertise in wire and catheter materials support their roles in enabling sensor integration across catheter types.
Collectively these ten companies cover the spectrum from sensor‑embedded guidewires and contact‑force or pressure‑sensing diagnostic catheters to mapping/ablation systems and integrated cath‑lab platforms; market reports and industry analyses list these firms repeatedly as market leaders or key competitors in cardiac catheter, guidewire, and sensor‑based catheter segments due to their product breadth, regulatory footprints, and R&D pipelines. Their strategic activities include product launches, CE and FDA clearances, acquisitions and partnerships to combine sensing, imaging, and navigation, and continued investment in pulsed‑field, contact‑force, and pressure/flow sensor technologies that aim to streamline procedures and provide real‑time physiological data to clinicians.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.